Patrick Caplazi
0000-0002-3411-1257
Genentech Research
2 papers found
Refreshing results…
Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone
TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis
Missing publications? Search for publications with a matching author name.